Chinese transcatheter aortic valve technology specialist Venus MedTech Inc. is further expanding its product portfolio as well as its geographic presence with the acquisition of InterValve Inc., a privately-held US developer of balloon aortic valvuloplasty products.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?